论文信息 - A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII. - 字舞流文

A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

C. Kempton | C. Kessler | B. Ritchie | J. Mahlangu | I. Warrier | A. Shapiro | N. Ewing | M. Reding | R. Gruppo | E. Libby | C. Walsh | W. Hoots | D. Macfarlane | T. Andreeva | J. St-Louis | N. Zozulya | J. N. Mueksch